Model Training– tag –
-
Kanerika Unveils Custom LLM Development Services for Enterprises, Emphasizing Robust Governance and Compliance for Regulated Industries
Kanerika India Overview Kanerika has launched custom LLM development services for enterprise teams, with a strong focus on enterprise-grade governance and compliance for regulated industries. Their solutions feature a governed LLM archit... -
MDPI Warns: Over $100 Billion Investment in AI Drug Discovery Fails to Improve Clinical Trial Success Rates, Citing Validation and Regulatory Gaps
MDPI Switzerland Overview A report from MDPI reveals that despite over $100 billion invested in AI in life sciences from 2022-2026, the clinical impact on drug discovery remains unclear, with no consistent improvement in the high clinica... -
OpenAI Inks $38 Billion, 7-Year Computing Deal with Amazon AWS, Expands Partnerships with Apple and Reddit
Britannica Money USA Overview OpenAI has signed a substantial $38 billion, seven-year computing infrastructure agreement with Amazon Web Services (AWS) to bolster its advanced AI model training and operations, including agentic AI. This ... -
Google Cloud Significantly Expands AI Infrastructure in Asia-Pacific with New High-Performance GPU Cluster Deployments
Google Cloud Blog USA Overview Google Cloud has announced a substantial expansion of its AI infrastructure in the Asia-Pacific region, commencing the deployment of new high-performance GPU clusters. This strategic investment directly add... -
2026 AI Chip Market Sees 44.6% Surge in Cloud Provider Custom ASIC Shipments, Challenging NVIDIA’s GPU Dominance
AIMultiple International Overview In the 2026 AI chip market, while NVIDIA's GPUs remain central, custom ASIC shipments from cloud providers are surging 44.6% year-over-year, reshaping the market structure. AIMultiple's analysis shows AS... -
FDA Approves First AI-Designed Drug Molecule for Phase 3 Clinical Trial in 2026, Accelerating R&D with New AI Drug Discovery Regulatory Guidance
BioNixus USA Overview In March 2026, the US FDA approved the first AI-designed drug molecule for Phase 3 clinical trials, solidifying AI drug discovery as a foundational technology in pharmaceutical R&D. Following this, on May 15th, ... -
arXiv Paper: Looped World Models (LoopWM) Achieve 100x Parameter Efficiency, Resolving Fidelity-Cost Tension in Long-Horizon AI Simulation
arXiv (cs.LG) International Overview Researchers have introduced Looped World Models (LoopWM), the first looped architectures for world modeling that resolve the tension between faithful long-horizon simulation and deployment costs. Loop... -
Deep Learning Framework Improves Doppler Shift Modeling in Radial-Velocity Data Under Stellar Activity Towards Earth-Mass Exoplanet Detection
arXiv (via Astrobiology) International Overview A new deep-learning framework aims to improve the detection of Earth-mass exoplanets by accurately modeling Doppler shifts in radial-velocity data, even in the presence of stellar activity.... -
AI Startup Funding Surges: TensorWave Secures $350M, Cyera $600M, Recursive $650M, Powering Infrastructure and Security Sectors
Scouts by Yutori USA Overview Over the past seven days, multiple large funding rounds for AI startups have been announced, indicating robust investor demand in AI infrastructure and security. TensorWave secured $350 million for AMD-based... -
AI/ML Transforms Drug Discovery, Boosting Efficiency and Precision from Target to Clinic
PubMed Central (Preprints経由) International Overview A recent review underscores the transformative impact of AI and Machine Learning (AI/ML) across the entire drug discovery pipeline, from initial target identification to clinical tria...
